Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BME/LAB stock hub

BME/LAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BME/LABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

58.7M

Madrid Stock Exchange

Market data

Price

Recent price action with selectable time range.

BME/LABBME/LAB

—

Loading chart…

In the news

Latest news · BME/LAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.9

P25 n/aP50 n/aP75 n/a

Trailing P/E54.9

P25 n/aP50 n/aP75 n/a

ROE23.1

P25 n/aP50 n/aP75 n/a

ROIC17.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BME/LAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

187

Groups with data

Currency

EUR

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	ES
Employees	394
Employees Change	25%
Employees Change Percent	6.78
Enterprise value	EUR 89.9M
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	ES0105638003
Last refreshed	2026-05-10
Market cap	EUR 58.7M
Price	EUR 7.1
Price currency	EUR
Rev Per Employee	181,914.65x
Sector	Healthcare
Sic	2834
Symbol	bme/LAB
Website	https://www.labiana.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.54%
EV Earnings	99.42x
EV/EBIT	14.38x
EV/EBITDA	9.58x
EV/FCF	1,339.18x
EV/Sales	1.25x
FCF yield	0.11%
Forward P/E	15.85x
P/B ratio	16.28x
P/E ratio	54.92x
P/S ratio	0.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.73%
EBITDA Margin	13.09%
FCF margin	0.09%
Gross margin	56.74%
Gross Profit	EUR 40.7M
Gross Profit Growth	4.53%
Gross Profit Growth Q	7.81%
Gross Profit Growth3 Y	7.57%
Gross Profit Growth5 Y	5.74%
Net Income	EUR 904,362
Net Income Growth Q	54.85%
Pretax Margin	0.8%
Profit Margin	1.26%
Profit Per Employee	EUR 2,295
ROA	7.43
Roa5y	0.81
ROCE	19.39
ROE	23.11
Roe5y	-37.51
ROIC	17.46
Roic5y	1.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	122.93%
Cagr3y	34%
EPS Growth Q	55.86
FCF Growth5 Y	-48.74%
OCF Growth5 Y	-7.42%
Revenue Growth	8.37x
Revenue Growth Q	12.07x
Revenue Growth3 Y	6.28x
Revenue Growth5 Y	3.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.36
Assets	EUR 54.4M
Cash	EUR 3.8M
Current Assets	EUR 31.3M
Current Liabilities	EUR 22.1M
Debt	EUR 36M
Debt EBITDA	EUR 3.83
Debt Equity	EUR 9.98
Debt FCF	EUR 536
Equity	EUR 3.6M
Interest Coverage	1.2
Liabilities	EUR 50.8M
Long Term Assets	EUR 23.1M
Long Term Liabilities	EUR 28.6M
Net Cash	EUR -32.2M
Net Cash By Market Cap	EUR -54.89
Net Debt EBITDA	EUR 3.43
Net Debt Equity	EUR 8.94
Net Debt FCF	EUR 480
Tangible Book Value	EUR 4.3M
Tangible Book Value Per Share	EUR 0.61
WACC	9.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.42
Inventory Turnover	2.64
Net Working Capital	EUR 12.8M
Quick ratio	0.86
Working Capital	EUR 9.2M
Working Capital Turnover	EUR 8.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	122.81%
200-day SMA	4.6
3Y total return	140.64%
50-day SMA	5.38
50-day SMA vs 200-day SMA	50over200
All Time High	8.2
All Time High Change	-13.41%
All Time High Date	2026-04-29
All Time Low	1.05
All Time Low Change	576.19%
All Time Low Date	2023-10-18
ATR	0.51
Beta	0.62
Beta1y	-0.65
Beta2y	-0.09
Ch YTD	46.69
High	7.4
High52	8.2
High52 Date	2026-04-29
High52ch	-13.41%
Low	6.95
Low52	3.14
Low52 Date	2025-05-28
Low52ch	126.12%
Ma50ch	32.02%
Price vs 200-day SMA	54.31%
RSI	64.04
RSI Monthly	75.15
RSI Weekly	75.85
Sharpe ratio	1.8x
Sortino ratio	3.26
Total Return	0.65%
Tr YTD	49.15
Tr1m	44.9%
Tr1w	-5.96%
Tr3m	68.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 6.3M
Operating Income Growth	23.02
Operating Income Growth Q	29.05
Operating margin	8.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	330,055
Shares Institutions	0.5%
Shares Out	8,263,172
Shares Yo Y	-0.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 67,138
Average Volume	31,708.65x
Bv Per Share	0.65
CAPEX	EUR -3.1M
Ch1m	44.9
Ch1w	-5.96
Ch1y	119.1
Ch3m	65.89
Ch3y	136.7
Ch6m	61.36
Change	-5.33%
Change From Open	-4.05
Close	7.5
Days Gap	-1.33
Depreciation Amortization	3,130,665
Dollar Volume	196,002.6
Earnings Date	2026-04-21
EBIT	EUR 6.3M
EBITDA	EUR 9.4M
EPS	EUR 0.13
F Score	6
FCF	EUR 67,138
FCF EV Yield	0.07x
FCF Per Share	EUR 0.01
Financing CF	346,301
Fiscal Year End	December
Founded	1,958
Graham Number	1.37827
Graham Upside	-80.59
Income Tax	EUR -278,386
Investing CF	-3,672,821
Is Primary Listing	1
Last Earnings Date	2026-04-21
Last Report Date	2025-06-30
Ma150	4.8
Ma150ch	47.89%
Ma20	6.13
Ma20ch	15.77%
Net CF	-145,290
Open	7.4
P FCF Ratio	873.8
P OCF Ratio	18.44
Position In Range	33.33
Ppne	13,149,624
Price Date	2026-05-08
Price EBITDA	EUR 6.25
Ptbv Ratio	13.67
Relative Volume	0.87x
Revenue	71,674,371x
Tax By Revenue	-0.39x
Tr6m	64.07%
Volume	27,606
Z Score	2.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BME/LAB pay a dividend?

Capital-return profile for this ticker.

Performance

BME/LAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BME/LAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.6%

Negative means the company is buying back shares.

Technical

BME/LAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.0

Neutral momentum band

Price vs 200-day MA

+54.3%

50/200-day relationship not available

Beta (5Y)

0.62

Less volatile than the market

Sharpe ratio

1.80

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BME/LAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/LAB stock rating?

bme/LAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/LAB analysis?

The full report lives at /stocks/bme/LAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/LAB?

The latest report frames bme/LAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/LAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.